InvestorsHub Logo

Stockdoggy

11/11/17 7:28 AM

#3123 RE: biopa #3122

I agree with you. Despite the negative spin lately, I really do,not think there is much risk. Management is mediocre but this seems really hard to mess up (of course, they did actually recently run out of pills to sell, so who knows). I think management is on a short leash and if they cannot increase sales shortly, the company will be sold. I originally bought into this stock at 14 cents and have traded around a core ever since. There have been a lot of twists and turns but I have been selling some other stocks for money to buy more Kerx in the last few days. One thing I never would have predicted is that share price would be this low after approval. Crazy...